Tumour necrosis factor-alpha antagonists for treatment of paediatric Crohn’s disease

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the efficacy and safety of tumour necrosis factor-alpha antagonists for induction of remission in children with active Crohn's disease.

This is a protocol.

Published:

27 May 2022

Authors:

Gana JC, Sepúlveda A, Orlanski-Meyer E, Villarroel del Pino LA, de la Piedra Bustamante MJ, Olivares Labbe MT

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Gana JC, SepúlvedaA, Orlanski-MeyerE, Villarroel del PinoLA, de la Piedra BustamanteMJ, Olivares LabbeMT.Tumour necrosis factor-alpha antagonists for treatment of paediatric Crohn’s disease (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD014497. DOI: 10.1002/14651858.CD014497.